PETS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Petmed Express Inc (PETS) is not a strong buy for a beginner investor with a long-term focus at this time. Despite insider buying activity, the company's financial performance shows declining revenue and gross margin, which raises concerns about its growth potential. Additionally, the lack of significant positive catalysts or strong trading signals suggests waiting for better entry points.
The MACD is positive but contracting, RSI is neutral at 53.87, and moving averages are converging, indicating no clear trend. Key support is at 2.25, and resistance is at 2.421. The technical indicators suggest a neutral stance.
Insider buying has increased by 174.01% over the last month, indicating potential confidence from insiders.
Revenue dropped by 21.75% YoY in Q3 2026, and gross margin declined by 19.33% YoY. The stock shows a 50% chance of declining by -3.35% in the next month based on historical patterns. No recent news or significant events to drive positive sentiment.
In Q3 2026, revenue dropped to $40.66M (-21.75% YoY), while net income improved to -$10.55M (+1392.64% YoY). EPS increased to -0.5 (+1566.67% YoY), but gross margin declined to 22.58% (-19.33% YoY). Overall, the financials show weak revenue and margin performance despite improvements in net income and EPS.
No recent analyst ratings or price target changes are available for evaluation.
